References
- Anderson G., Wilkins E. A trial of clenbuterol in bronchial asthma. Thorax 1977; 32: 717–7191. Anderson G., Wilkins E. A trial of clenbuterol in bronchial asthma. Thorax 1977; 32: 717–719
- Brusasco V., Crimi E., Mangini S., Vibelli C. A clinical trial of oral clenbuterol (NAB 365) in chronic airways obstruction. Curr. Med. Res. Opin. 1980; 6: 449–4552. Brusasco V., Crimi E., Mangini S., Vibelli C. A clinical trial of oral clenbuterol (NAB 365) in chronic airways obstruction. Curr. Med. Res. Opin. 1980; 6: 449–455
- Cummiskey J., Keelan P., Gray P., Cox G. A. Comparison of NAB 365 and salbutamol tablets in chronic bronchitis and asthma. J. Irish Med. Assoc. 1978; 71: 123–1263. Cummiskey J., Keelan P., Gray P., Cox G. A. Comparison of NAB 365 and salbutamol tablets in chronic bronchitis and asthma. J. Irish Med. Assoc. 1978; 71: 123–126
- von Engelhardt G. Pharmakologiscbés Wirkungsprofil von NAB 365 (clenbuterol) einem neunen Broncholytikum mit einer selektiven Wirkung auf die Adrenergen β2-Rezeptoren. Arzneim. Forsch. 1976; 26: 1404–14204. von Engelhardt G. Pharmakologiscbés Wirkungsprofil von NAB 365 (clenbuterol) einem neunen Broncholytikum mit einer selektiven Wirkung auf die Adrenergen β2-Rezeptoren. Arzneim. Forsch. 1976; 26: 1404–1420
- Kamburoff P. L., Prime F. J., Schmidt O. P. The bronchodilator effect of NAB 365. Br. J. Clin. Pharmacol. 1977; 4: 67–715. Kamburoff P. L., Prime F. J., Schmidt O. P. The bronchodilator effect of NAB 365. Br. J. Clin. Pharmacol. 1977; 4: 67–71
- Keelan P., Gray P., Cox G. A. A multiple-dose response study of clenbuterol in bronchial asthma. Irish Med. J. 1980; 73: 382–3846. Keelan P., Gray P., Cox G. A. A multiple-dose response study of clenbuterol in bronchial asthma. Irish Med. J. 1980; 73: 382–384
- Mazzola C., Vibelli C. Evaluation of cardiovascular effects and skeletal muscle tremor after acute oral administration of clenbuterol, a new brochodilator drug, to normal human subjects. Curr. Ther. Res. 1978; 23: 321–3297. Mazzola C., Vibelli C. Evaluation of cardiovascular effects and skeletal muscle tremor after acute oral administration of clenbuterol, a new brochodilator drug, to normal human subjects. Curr. Ther. Res. 1978; 23: 321–329
- O'Donnell S. R. Selectivity of clenbuterol (NAB 365) in guinea-pig isolated tissues containing β-adrenoceptors. Arch. Int. Pharmacodyn. Ther. 1976; 224: 190–1988. O'Donnell S. R. Selectivity of clenbuterol (NAB 365) in guinea-pig isolated tissues containing β-adrenoceptors. Arch. Int. Pharmacodyn. Ther. 1976; 224: 190–198
- Pasotti C., Capra A., Vibelli C. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial. Int. J. Clin. Pharmacol. Biopharm. 1979; 17: 176–1809. Pasotti C., Capra A., Vibelli C. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial. Int. J. Clin. Pharmacol. Biopharm. 1979; 17: 176–180
- Salorinne Y., Stenius B., Tukiainen P., Poppius H. Double-blind crossover comparison of clenbuterol and salbutamol tablets in asthmatic out-patients. Eur. J. Clin. Pharmacol. 1975; 8: 189–19510. Salorinne Y., Stenius B., Tukiainen P., Poppius H. Double-blind crossover comparison of clenbuterol and salbutamol tablets in asthmatic out-patients. Eur. J. Clin. Pharmacol. 1975; 8: 189–195
- Wheatley D. Psychopharmacology in Family Practice. Heinemann, London 1973; 3411. Wheatley D. Psychopharmacology in Family Practice. Heinemann, London 1973; 34
- von Zimmer A. Einmalapplikation, Mehrfachapplikation und Metabolitenmuster von Clenbuterol beim Menschen. Arzneim. Forsch. 1976; 26: 1446–145012. von Zimmer A. Einmalapplikation, Mehrfachapplikation und Metabolitenmuster von Clenbuterol beim Menschen. Arzneim. Forsch. 1976; 26: 1446–1450